Key Highlights

  • RadNet shares rose approximately 6.20 percent in pre-market trading to $72.39, extending Friday's post-earnings rally.
  • Second quarter Revenue grew 25 percent year over year to $622.7 million, beating consensus estimates of roughly $609 to $614 million.
  • Adjusted EPS of $0.29 topped expectations of $0.19 to $0.20, with adjusted EBITDA of $99.7 million up 22.7 percent.
  • The company raised full-year Imaging Center guidance for the second time this year, while Digital Health ARR grew nearly 97 percent year over year.

Record Quarter Beats Across Every Key Metric

RadNet, Inc. ( Nasdaq :RDNT), the largest provider of freestanding outpatient diagnostic imaging services in the United States, traded higher in pre-market activity following a second quarter report that beat expectations on nearly every measure. Revenue grew 25 percent year over year to $622.7 million, ahead of the roughly $609 to $614 million consensus, while adjusted EPS of $0.29 topped estimates of $0.19 to $0.20 and adjusted EBITDA reached $99.7 million, up 22.7 percent.

Digital Health Segment Drives the Upside

A key contributor to the beat was the company's Digital Health segment, where annual Recurring Revenue grew nearly 97 percent year over year, reflecting momentum in RadNet's AI-driven radiology solutions, picture archiving systems, and teleradiology services. This segment has increasingly become a differentiator beyond core imaging center operations, giving RadNet a technology-driven growth lever.

Guidance Raised for Second Time This Year

The core Imaging Center segment also performed well, with revenue up 5.6 percent, prompting management to raise full-year guidance for that segment for the second time in 2026, suggesting underlying Demand trends have continued to strengthen through the year.

Valuation Debate Emerges Despite Strong Fundamentals

Despite the strong quarter, some valuation metrics, including a GF Value model, flagged shares as potentially Overvalued by roughly 12.5 percent relative to historical price-to-sales multiples, a tension that could shape trading once Earnings enthusiasm settles.

Conclusion

RadNet's pre-market rally reflects a genuine beat-and-raise quarter, with strength evident across both its legacy imaging Business and its faster-growing Digital Health segment. Whether the stock can sustain this move may depend on how the market reconciles continued fundamental strength with valuation concerns that have already begun to surface.